Inactive Instrument

Press Releases Ignyta Inc

Equities

US4517311035

Press Releases

Unlock all the news: Be the first to know and act before the market!

Ignyta : Reports FDA Clearance of IND for RXDX-106, a Novel Immunomodulatory Agent and TYRO3, AXL, MER (TAM) Inhibitor	17-12-29	BU
Ignyta : Roche and Ignyta Reach Definitive Merger Agreement	17-12-22	BU
Ignyta : to Participate at the Global Mizuho Investor Conference	17-11-29	BU
Ignyta : to Present at the 29th Annual Piper Jaffray Healthcare Conference	17-11-22	BU
Ignyta : Reports Granting of Inducement Awards	17-11-16	BU
Ignyta : to Present at the Jefferies 2017 London Healthcare Conference	17-11-09	BU
Ignyta : Announces New Data Highlighting Immune Modulation of RXDX-106 at the Society for Immunotherapy of Cancer (SITC) Meeting	17-11-08	BU
Ignyta : Announces Third Quarter 2017 Company Highlights and Financial Results	17-11-07	BU
Ignyta : to Present at Credit Suisse 26th Annual Healthcare Conference	17-11-01	BU
Ignyta : Announces Pricing of Public Offering of Common Stock	17-10-19	BU
Ignyta : Announces Proposed Public Offering of Common Stock	17-10-18	BU
Ignyta : Interim Analysis of Ignyta’s Entrectinib Suggests Potential Best-in-Class Profile as a First-Line Targeted Therapy in Patients With ROS1-Positive Non-Small Cell Lung Cancer	17-10-17	BU
Ignyta : Receives European Medicines Agency Prime Designation for Entrectinib in NTRK Fusion-Positive Solid Tumors	17-10-17	BU
Ignyta : Reports Granting of Inducement Awards	17-10-16	BU
Ignyta : Announces New Data Highlighting Immuno-Oncological Efficacy of RXDX-106 at 2017 AACR Tumor Immunology and Immunotherapy Meeting	17-10-02	BU
Ignyta : Announces Updated Data on Entrectinib in ROS1 NSCLC to Be Presented at the IASLC 18th World Conference on Lung Cancer	17-09-27	BU
Ignyta : to Present at Cantor Fitzgerald 2017 Global Healthcare Conference	17-09-20	PU
Ignyta : to Present at the Ladenburg Thalmann 2017 Healthcare Conference	17-09-18	BU
Ignyta : Reports Granting of Inducement Awards	17-09-15	BU
Ignyta : Provides Update on Entrectinib and RXDX-105 at the ESMO 2017 Congress	17-09-11	BU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Ignyta Inc

Equities

US4517311035

Press Releases

Filters